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Background/aim: This study aimed to describe the spectrum and frequency of cardiovascular abnormalities in pediatric and young
adult patients with Turner syndrome (TS) using cardiac MRI and MR angiography.
Materials and methods: This prospective study consisted of 47 female patients of pediatric age and young adults with a karyotypically
confirmed diagnosis of TS. All patients underwent cardiac MRI and contrast-enhanced MR angiography. A second examination after
9–26 months was performed for 28 of these patients.
Results: Elongation of the transverse aortic arch (ETA) was the most frequent abnormality with a rate of 37%. The rate of partial
anomalous pulmonary venous connection (PAPVC) was 21.7%, bicuspid aortic valve (BAV) was 19.6%, coarctation was 6.5%, ascending
aorta dilatation was 28.3%, and descending aorta dilatation was 15.2%. The diameters of the aorta and the rate of aortic dilatation per
unit of time was greater in the patients with BAV (P < 0.05). ETA was less observed in the patients who were receiving growth hormone
therapy (P < 0.05).
Conclusion: The most common cardiovascular abnormalities in TS patients are aortic arch anomalies such as ETA and coarctation,
aortic dilatation, PAPVCs, and BAV. The presence of BAV is an important risk factor for the aortic dilatation.
Key words: Ullrich–Turner syndrome, cardiovascular system, aortic arch, magnetic resonance imaging, magnetic resonance angiography

1. Introduction
Turner syndrome (TS) is a genetic disorder characterized
by the loss of all or a part of one of the sex chromosomes,
and it occurs in 1 in 2500 live-born females (1,2). In
these patients, cardiovascular assessment and follow-up
are important as complications can be life-threatening.
Transthoracic echocardiography (TTE) is the primary
examination method for assessing these patients,
while cardiac MRI and MR angiography are used as
supplementary methods (3–8). There are many MRI
studies of adult TS patients; however, those addressing
pediatric and young adult patients are quite limited (8–
11). The current study carried out cardiac MRI and MR
angiography in pediatric and young adult patients with TS.
2. Materials and methods
The study included 47 female pediatric or young adult
patients with a karyotypically confirmed diagnosis of
TS. The detailed medical history of the participants was
* Correspondence: hayigit@hotmail.com

recorded and anthropometric assessments were performed.
All patients underwent cardiac MRI and contrast-enhanced
MR angiography. A second examination after 9–26
months (mean interval: 16.6 months) was performed in 28
of these patients to compare changes in measurements per
unit of time. This prospective study was approved by the
institutional review board and written informed consent
was obtained from all patients.
2.1. Cardiac MRI and MR angiography
Magnetic resonance examinations were performed at 1.5
T (Signa HDi, GE Healthcare, Milwaukee, WI, USA). An
eight-channel torso surface coil (8-ch Body Array; Invivo
Corporation, Gainesville, FL, USA) was used for all data
acquisition. None of the patients required sedation or
anesthesia.
Cardiac functional and morphological assessments
were made using balanced steady-state free precession
(b-SSFP) sequences. Cine images of the following views
were obtained: two-, three-, and four-chamber long-axis
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views; a short-axis stack from the cardiac base to apex; a
coronal left ventricular outflow tract view; axial sections
through the aortic valve plane; and double-oblique
sagittal candy-cane stack for the aortic view. Additionally,
straight axial sections, starting at the supraaortic level and
covering the entire heart, were obtained to reveal cardiac
and vascular anatomy. Furthermore, through-plane cine
phase-contrast flow imaging was performed above and
at the aortic valve plane, and at coarctation level when
applicable.
Three-dimensional MR angiography was performed in
coronal or oblique coronal 3D spoiled gradient-echo pulse
sequences before and after contrast injection. A single dose
(0.1 mmol/kg) of gadolinium-based contrast medium was
administered i.v. using a power injector. The exact timing
of MR angiography was achieved using automated bolus
detection and acquisition triggering software (Smartprep,
GE Medical Systems).
The imaging parameters of used sequences are listed
in Table 1.
2.2. Image analysis
Image analysis was performed on a remote workstation
(Advantage Windows, version 4.3; GE Medical Systems)
by one radiologist who had 5 years of experience in
cardiovascular MR imaging.
Cardiac measurements and functional assessments
were made using cardiac analysis software (ReportCard
2.0; GE Medical Systems). The aortic valve area was
measured in axial images obtained from the aortic valve
plane. Maximum velocities were measured via phasecontrast velocity-encoded cine MR imaging, and the
pressure gradient (∆P) was estimated using the modified
Bernoulli’s equation ∆P = 4(v2) (12). In patients with aortic
regurgitation, the regurgitant volume and regurgitant
fraction were calculated.
During MR angiography, source images, subtraction
images, 2D multiplanar reconstructed (MPR) images, and
3D maximum intensity projection (MIP) angiograms were

interpreted. Diameter measurements were performed on
oblique MPR images, which were obtained perpendicular
to the centerline of the vessel. The diameter of the
ascending aorta at the level of the right pulmonary artery
was defined as the ascending aortic diameter, whereas the
diameter of the descending aorta at the same level was
defined as the descending aorta diameter. The diameter of
the aortic sinus was defined as the aortic root diameter.
A standardized Z-score was calculated for the ascending
and descending aorta according to the method defined
by Kaiser et al. (13). Aorta diameter and body surface
area (BSA) were used and the Z-score was calculated by
subtracting the measured diameter from the predicted
diameter and dividing by the SD of residuals. In addition,
the ratio of the ascending aorta diameter at the level of the
right pulmonary artery to the diameter of the descending
aorta at the same level was calculated for each patient (AD/
DD). Furthermore, the aortic size index (ASI), indexing
the ascending aorta directly with the BSA, was calculated.
In addition to diameter measurements, the aortic
arch, branching anomalies, and venous anomalies were
assessed. Elongation of the transverse aortic arch (ETA)
was defined as the presence of a posterior origin of the left
subclavian artery behind the trachea on axial images and
an inward indentation or convex kinking of the inferior
aortic contour along the lesser curvature (14).
BSA-corrected index values were used for all
measurements and calculations. BSA was determined by
the Mosteller formula (15). Intracardiac areas were indexed
directly by BSA. Since linear dimensions and volumes had
a nonlinear relation to BSA, they were indexed using BSA
to the power 0.5 and 1.5, respectively (16,17).
2.3. Statistical analysis
Associations between categorical and quantitative
variables were analyzed using one-way ANOVA, whereas
associations between categorical variables were analyzed
using Pearson’s chi square (χ2) test and Fisher’s exact
test. Statistical significance was set at P < 0.05. Statistical

Table 1. Imaging parameters in cardiac MRI and MR angiography sequences.
Parameter

Cine b-SSFP*

Phase-contrast flow
imaging

MR angiography

Sequence

2D FIESTA

Fast 2D PC

3D FSPGR

TR (ms)/TE (ms)

3.4–3.9/1.5–1.7

7–7.8/4–4.7

3.5–3.7/1.3–1.4

Flip angle (°)

55

25-30

30

Slice thickness (mm)/gap (mm)

6–8/0

6–8/0

3.6/–2.7

FOV (cm )

30–31

29–31

32

Matrix

256 × 200

192 × 128

352 × 224

2

*b-SSFP: Balanced steady-state free precession.
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analysis was performed using Predictive Analytics
Software version 18 (PASW 18, SPSS, Chicago, IL, USA).
3. Results
It should be taken into account that all data given in this
section are BSA-corrected data, indexed by BSA to the
power of 0.5, 1.0, or 1.5 for linear dimensions, areas, and
volumes, respectively.
3.1. Clinical data
The mean age of patients was 14.3 years (age range: 7–22
years). The clinical data of the patients are summarized in
Table 2.
3.2. Aortic arch and branching anomalies
The rate of ETA was 37% (Figure 1). Of ETA components,
an inferior kink was observed at a rate of 56.5%, and
subclavian late takeoff at a rate of 58.7%. Flattening on the
transverse arch was found at a rate of 52.2%. Coarctation
was found in three (6.5%) patients.
ETA was observed less frequently in patients receiving
growth hormone (GH) therapy (5/25) compared to patients
who were not (13/22; P < 0.05). Flattening at the aortic
arch and late takeoff of the subclavian artery were also
observed less frequently in patients who were receiving
GH therapy (8/26, 11/26, respectively) compared to those
who were not (16/21, 16/21, respectively; P < 0.05).
Mean aortic valve area was lower in patients with ETA
(158.08 ± 42.82 mm2/BSA) compared to those without
ETA (178.34 ± 22.66 mm2/BSA; P < 0.05). Mean Z-score
for the descending aorta was higher in the patients with an
inferior kink (1.33 ± 1.37) compared to those without the
same (0.60 ± 0.87; P < 0.05). Mean Z-score and diameter
of the ascending aorta were higher in patients with late

takeoff (2.16 ± 2.51, 21.63 ± 4.76 mm/BSA0.5, respectively)
compared to those without the same (0.91 ± 1.07, 19.17 ±
1.89 mm/BSA0.5, respectively) and with flattened arch (2.23
± 2.61, 21.75 ± 4.93 mm/BSA0.5, respectively) compared
to those without the same (1.01 ± 1.15, 19.37 ± 2.13 mm/
BSA0.5, respectively; P < 0.05). The presence of ETA was
found to be associated with coarctation (P < 0.05). In flow
assessments, the peak pressure gradient was around 24–25
mmHg in the related area in two patients with coarctation
compared to 12 mmHg in one patient.
Bovine-type aortic arch variation was found at a rate
of 10.6%.
3.3. Venous abnormalities
Partial anomalous pulmonary venous connections
(PAPVCs) were found in 21.7% of the patients. Of these,
six were in the form of a vertical vein, where some of the
upper left pulmonary vein branches were flowing into the
left brachiocephalic vein. Furthermore, abnormal venous
connections associated with right pulmonary veins were
identified in three patients. Both the vertical veins on the
left and abnormal venous connections associated with the
right pulmonary veins were observed in one patient (Figure
2). PAPVCs were observed at a higher rate in patients with
the 45,X karyotype (8/24) compared to patients without
the same (1/23 patients; P < 0.05).
The occurrence of a persistent left superior vena
cava (LSVC) was 8.7%. The mean ascending aorta and
aortic root diameters were higher in the patients with
LSVC (27.20 ± 7.64 mm/BSA0.5, 26.73 ± 5.77 mm/BSA0.5,
respectively) compared to patients without (19.99 ± 2.94
mm/BSA0.5, 21.54 ± 2.23 mm/BSA0.5, respectively; P <
0.05).

Table 2. Characteristics of patients.
Total subjects (n)
Age (years, range & mean ± standard deviation)

47
7–22 (14.3 ± 3.5)

BSA, (m2, mean ± standard deviation)

1.18 ± 0.2

Subjects with 45,X karyotype (n & percent)

24 (51%)

Subjects with other karyotypes (mosaics, isochromosomes) (n & percent)
Subjects with history of GH therapy (n & percent)

23 (49%)
39 (83%)

Duration of GH therapy (months, range & mean ± standard deviation)

5–84 (36.5 ± 19.9)

Subjects still receiving GH (n & percent)

25 (53.2%)

Subjects with history of estrogen therapy (n & percent)

26 (55.3%)

Duration of estrogen therapy (months, range & mean ± standard deviation)

1–86 (22.1 ± 21.4)

Subjects with history of combined estrogen and progesterone therapy (n & percent)

13 (27.7%)

Duration of combined estrogen and progesterone therapy (months, range & mean ± standard deviation)

1–60 (24.6 ± 15.1)

Subjects with webbed neck (n & percent)

19 (40.4%)

Subjects with lymphedema (n & percent)

13 (27.7%)
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Figure 2. Bilateral PAPVCs in a 16-year-old girl with TS. 3D
volume rendering image shows a vertical vein draining in to the
left brachiocephalic vein (white arrow). In addition, right upper
and middle lobe veins are draining into the superior vena cava
(black arrow).

Figure 1. ETA in a 15-year-old girl with TS. a) 3D volume
rendering image shows flattening of the aortic arch (white arrow)
and convex kinking along the lesser curvature (black arrow) b)
Axial b-SSFP image reveals posterior origin of the left subclavian
artery (open arrow) behind the trachea (asterisk).

3.4 Aortic valve
The aortic valve was bicuspid in 19.6% of the patients. The
mean diameters of the descending and ascending aorta and
mean Z-score for the ascending aorta were significantly
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higher in patients with bicuspid aortic valve (BAV; 16.27
± 2.62 mm/BSA0.5, 23.36 ± 5.17 mm/BSA0.5, 3.01 ± 2.56,
respectively) compared to those with tricuspid aortic valve
(14.77 ± 1.44 mm/BSA0.5, 19.95 ± 3.42 mm/BSA0.5, 1.31 ±
1.89, respectively; P < 0.05). Mean aortic valve area was
significantly lower in patients with BAV (147.95 ± 45.29
mm2/BSA) compared to those without the same (176.42
± 26.78 mm2/BSA; P < 0.05). The presence of BAV was
found to be associated with aortic regurgitation (P < 0.05).
The difference in the ascending aorta diameters measured
in the first and second MRI assessments of patients with
BAV was significantly higher compared to the group with
tricuspid aortic valve (74 mm/BSA0.5 vs. –0.50 mm/BSA0.5
and 0.04 mm/month/BSA0.5 vs. –0.03 mm/month/BSA0.5,
respectively). No association was found between the
presence of BAV and ETA (P > 0.05).
Aortic regurgitation was identified in eight (17%)
patients. The mean diameter of the aortic root and ascending
aorta and the Z-scores were higher in the patients with aortic
regurgitation (24.13 ± 5.43 mm/BSA0.5, 25.56 ± 5.63 mm/
BSA0.5, 4.34 ± 2.91, respectively) compared to those without
the same (21.43 ± 2.11 mm/BSA0.5, 19.58 ± 2.66 mm/BSA0.5,
1.08 ± 1.40, respectively; P < 0.05). Aortic regurgitation had
an association with indices indicating the dilatation of an
ascending aorta (Z-scores of >2 for ascending aorta, ASI
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>2 cm/m2, AD/DD >1.5), and the presence of LSVC and
webbed neck (P < 0.05).
3.5. Aortic diameter
The Z-score of the ascending aorta in 28.3% of the patients
and the Z-score of the descending aorta in 15.2% of the
patients were >2 (indicating dilatation of the aorta). Among
the indices used for the dilatation of aortic diameter, ASI
>2 cm/m2, which reflects dilatation of the ascending aorta,
was detected in 28.3% of the patients and ASI >2.5 cm/
m2, which is considered as a high risk for dissection, was
observed in four (8.7%) patients. AD/DD >1.5, another
index suggesting dilatation of the ascending aorta, showed
21.7% occurrence. The dilatation of the descending aorta,
determined by a Z-score of >2, was observed in 15.2%
instances. The coexistence of ascending and descending
aortic dilatation was 6.5%. A Z-score for aortic sinus of
>2, which indicates dilatation of the aortic root, was seen
in 10.9% patients.
Z-scores of >2 for the descending and ascending aorta
and the aortic root were correlated with the presence of
BAV, whereas a Z-score of >2 for the descending aorta was
correlated with the presence of ETA (P < 0.05). ASI of >2
cm/m2 was correlated with the presence of ETA (P < 0.05).
ASI of >2.5 cm/m2 was associated with BAV. The mean
ascending aortic diameter, the Z-score for the ascending
aorta, ASI, and aortic root width were all significantly
higher in the patients with webbed neck (22.36 ± 5.44 mm/
BSA0.5, 2.55 ± 2.83, 2.45 ± 0.56 cm/m2, 23.38 ± 3.41 mm/
BSA0.5, respectively) compared to those without the same
(19.47 ± 2.20 mm/BSA0.5, 1.04 ± 1.26, 1.79 ± 0.28 cm/m2,
20.79 ± 2.42 mm/BSA0.5, respectively; P < 0.05).
4. Discussion
The elongation of the transverse aortic arch (ETA) was
the most frequently reported cardiovascular abnormality
observed in our study population. Similar to the study by
Kim et al. (8), the present study included pediatric and
young adult patients, and the prevalence of ETA (37%)
was lower relative to other studies (47%–49%) conducted
with older adult TS patients (4), suggesting that the
findings become apparent with increasing age. Similar
to previous studies, the presence of ETA was associated
with coarctation; however, as opposed to previous
studies (4,8,13,18), no association was found between the
presence of ETA and the 45,X karyotype, the presence of
neck webbing, the presence of the LSVC, BAV, or aortic
dilatation. On the other hand, the late takeoff and flattening
of the arch was significantly associated with the diameter
and the Z-score of the ascending aorta. Convex kinking of
the inferior aortic contour was associated with Z-scores for
the descending aorta. The present study, which measured
the aortic valve area, suggested that the presence of ETA is
associated with smaller aortic valve area.

Coarctation is reported in TS patients at rates varying
from 5% to 20% (4,8,9,19). Coarctation has classically
sharp concavity in the outer wall of the aorta, whereas
kinking occurs at the lesser curvature in ETA (14,20). MR
angiography ensures the identification of coarctation and
collateral vascularization; it also allows the measurement
of aortic diameters at various levels, which is important
for surgical aspects. Moreover, phase-contrast velocityencoded cine MR imaging can present increased velocity
and peak pressure gradients at these levels, demonstrating
coarctation severity (12,21,22).
PAPVC is a common anomaly in TS patients and
it was found at a higher rate (22%) in the current study
relative to other studies (13%–18%) (4,8,14,23). A careful
assessment of all pulmonary venous branches is important
for MRI identification of PAPVCs, because in most of
these cases the aberrant vein appears as a thin vertical
vein. Our personal experience during daily practice is
that PAPVCs are easily missed even with MR angiography
if not specifically investigated by means of assessing the
pulmonary venous branches individually over thinslice source and MPR images. On the other hand, MR
angiography can easily display the entire vascular tree and
is evidently more advantageous than TTE, which provides
assessments from limited windows. This is proved by the
considerably higher incidence of PAPVCs in the studies
using Gd-enhanced 3D MR angiography compared
to others that did not use MR angiography (8,14,24).
PAPVC was typically left-sided in TS patients, which is
also different from that of non-TS patients, in whom it is
typically right-sided. Furthermore, the anomalous venous
return was typically isolated and was not associated with
intracardiac defects such as sinus venosus atrial septal
defect, as seen in non-TS subjects (14,24). Similar to some
of the previous studies, PAPVCs were associated with the
45,X karyotype (4,14,23) in the present study, whereas no
such association was demonstrated with neck webbing,
contrary to some of the previous studies.
BAV is a common cardiovascular anomaly in TS
patients and its incidence ranges widely from 1.5%
to 39.2% in TTE and MRI assessments (4,25). In the
present study, the aortic diameters and Z-scores of both
the ascending and descending aorta were higher in the
presence of BAV and the progression in the diameter of
the ascending aorta was greater in BAV cases. These results
suggest that patients with BAV are at greater risk for aortic
dilatation and thereby secondary complications. In the
study by Hahn et al., which included the ascending aorta
and investigated the association of aortic dilation with
bicuspid aortic valves (26), a high prevalence of aortic root
dilatation was reported in patients with a bicuspid aortic
valve that occurred irrespective of altered hemodynamics
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or age. The authors indicated that these findings support
the hypothesis that bicuspid aortic valve and aortic root
dilation may reflect a common developmental defect.
In the present study, the association of BAV with both
descending and ascending aorta dilatation also supports
this hypothesis. Ferencik et al., while investigating changes
in the size of the ascending aorta and aortic valve function
with time in patients with congenitally bicuspid aortic
valves, reported the mean rate of diameter progression at
various levels as 0.5–0.9 mm/year and concluded that that
progression of aortic diameter dilatation occurs irrespective
of baseline valve function in adult patients with BAV (27).
Mortensen et al. (28) evaluated 80 TS patients via two MR
angiography examinations and found that the presence of
BAV is associated with the progression in diameter of the
aortic sinus. In addition to the studies demonstrating an
association of BAV with aortic dilatation (28–30) in TS
patients, there are also some that do not demonstrate such
an association (8). The present study differs from earlier
ones by not demonstrating any association between the
presence of BAV and ETA (4,29).
Reference values in the present study for the ascending
and descending aorta and aortic root diameters were
based on the study of Kaiser et al. (13). Indices with the
diameter of the ascending aorta indexed by the diameter of
the descending aorta or BSA were also included; however,
these indices can only demonstrate dilation of the
ascending aorta. Therefore, a calculation of standardized
Z-scores is generally more valuable when deciding on aortic
dilatation. In the present study, a Z-score of >2 and ASI of
>2 cm/m2 for the ascending aorta produced the same result
with regard to determination of ascending aorta dilatation.
The rate of ascending aorta dilatation that was found based
on an AA/DA ratio of >1.5 was lower compared to these
methods (28.3% vs. 21.7%). Coexistence of ascending and
descending aorta dilatation in 6.5% of cases account for
this difference and presents the limitation of the AA/DA
ratio to demonstrate ascending aorta dilatation correctly
(29). Aortic dilatation reported in TS patients ranges
widely (12.5%%–50%) and this discrepancy may result
from differences in methodology, as well as the important
issue of defining dilation (9,10,29). Studies on TS patients

reported that BAV, aortic coarctation, ETA, and karyotype
45,X are associated with larger baseline aortic diameters
(28). In the present study, BAV, ETA and its components,
webbed neck, and LSVC were associated with larger
aortic diameters. In the study of Kim et al. (8), which
was conducted with a similar age-range patient group to
ours and used the same assessment method for Z-scores,
aortic sinus dilatation had a high incidence rate of 30%;
contrary to their findings, in the present study, the aortic
sinus dilatation was less than the rate of ascending and
descending aorta dilatations. Moreover, in contrast to
their study, no correlation was found between aortic root
dilatation and the presence of ETA.
GH therapy is widely used in TS patients to augment
adult height. In the current study, most of the patients
had a history of receiving GH and half of them were still
receiving therapy during assessments. It was remarkable
that ETA findings were observed at a lower rate in patients
receiving GH therapy. As far as we know, although there
is not another study evaluating the relation between GH
therapy and ETA, Berg et al. (31) stated that GH therapy
has a positive effect on aortic biophysical properties such as
aortic wall distensibility. The present study employed BSAcorrected data and did not demonstrate any association
between a history of using GH and aortic diameters; this
was consistent with the results of Bony et al. (32).
The main limitations of the present study were the
relatively small number of cases and absence of a normal
control group of similar age. Calculating Z-scores based
on the data of a single study (13) was another limitation.
Further studies are needed to validate the normal ranges of
aortic diameter in the pediatric population.
In summary, the most common anomaly, ETA, was
observed to a lower degree in patients who were receiving
GH therapy. Abnormal pulmonary venous returns are
common in TS patients and were observed more frequently
in the present study compared to rates reported in the
literature. The presence of BAV is an important risk factor
for aortic dilatation and its secondary complications, and
aortic dilatation per unit time is greater in patients with
BAV.
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